Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators.

Gemmati D, Occhionorelli S, Tisato V, Vigliano M, Longo G, Gonelli A, Sibilla MG, Serino ML, Zamboni P.

Sci Rep. 2018 Nov 16;8(1):16916. doi: 10.1038/s41598-018-35185-x.

2.

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity.

Biolo G, Di Girolamo FG, McDonnell A, Fiotti N, Mearelli F, Situlin R, Gonelli A, Dapas B, Giordano M, Lainscak M, Grassi G, Zauli G, Secchiero P, Mekjavic I.

Front Physiol. 2018 Jul 30;9:1000. doi: 10.3389/fphys.2018.01000. eCollection 2018.

3.

Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging.

Simioni C, Zauli G, Martelli AM, Vitale M, Sacchetti G, Gonelli A, Neri LM.

Oncotarget. 2018 Mar 30;9(24):17181-17198. doi: 10.18632/oncotarget.24729. eCollection 2018 Mar 30. Review.

4.

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.

Tisato V, Voltan R, Gonelli A, Secchiero P, Zauli G.

J Hematol Oncol. 2017 Jul 3;10(1):133. doi: 10.1186/s13045-017-0500-5. Review.

5.

Vaginal Lactoferrin Modulates PGE2, MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations.

Trentini A, Maritati M, Cervellati C, Manfrinato MC, Gonelli A, Volta CA, Vesce F, Greco P, Dallocchio F, Bellini T, Contini C.

Mediators Inflamm. 2016;2016:3648719. Epub 2016 Oct 31.

6.

Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.

Alameen AA, Simioni C, Martelli AM, Zauli G, Ultimo S, McCubrey JA, Gonelli A, Marisi G, Ulivi P, Capitani S, Neri LM.

Oncotarget. 2016 Aug 23;7(34):55690-55703. doi: 10.18632/oncotarget.10984.

7.

Association between circulatory levels of adipokines and bone mineral density in postmenopausal women.

Cervellati C, Bonaccorsi G, Bergamini CM, Fila E, Greco P, Valacchi G, Massari L, Gonelli A, Tisato V.

Menopause. 2016 Sep;23(9):984-92. doi: 10.1097/GME.0000000000000655.

PMID:
27433863
8.

Clinical perspectives of TRAIL: insights into central nervous system disorders.

Tisato V, Gonelli A, Voltan R, Secchiero P, Zauli G.

Cell Mol Life Sci. 2016 May;73(10):2017-27. doi: 10.1007/s00018-016-2164-7. Epub 2016 Feb 24. Review.

9.

TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.

Perri P, Zauli G, Gonelli A, Milani D, Celeghini C, Lamberti G, Secchiero P.

Biomed Res Int. 2015;2015:424019. doi: 10.1155/2015/424019. Epub 2015 Mar 5. Review.

10.

Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival.

Zauli G, Celeghini C, Monasta L, Martinelli M, Luppi S, Gonelli A, Grill V, Ricci G, Secchiero P.

Reproduction. 2014 Aug;148(2):191-8. doi: 10.1530/REP-14-0144. Epub 2014 May 13.

PMID:
24825910
11.

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells.

Tisato V, Norcio A, Celeghini C, Milani D, Gonelli A, Secchiero P.

Clinics (Sao Paulo). 2014 Jan;69(1):68-74. doi: 10.6061/clinics/2014(01)10.

12.

Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages.

Secchiero P, Rimondi E, di Iasio MG, Voltan R, Gonelli A, Zauli G.

J Cell Physiol. 2012 May;227(5):1829-37. doi: 10.1002/jcp.22910.

PMID:
21732354
13.

Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.

Corallini F, Celeghini C, Rimondi E, di Iasio MG, Gonelli A, Secchiero P, Zauli G.

J Cell Physiol. 2011 Sep;226(9):2279-86. doi: 10.1002/jcp.22564.

PMID:
21660951
14.

Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells.

Rimondi E, di Iasio MG, Gonelli A, Celeghini C, Secchiero P, Zauli G.

Invest New Drugs. 2012 Aug;30(4):1731-5. doi: 10.1007/s10637-011-9675-8. Epub 2011 May 4. No abstract available.

PMID:
21541705
15.

Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL.

Gonelli A, Radillo O, Drioli S, Rimondi E, Secchiero P, Maria Bonora G.

Invest New Drugs. 2012 Apr;30(2):828-32. doi: 10.1007/s10637-010-9599-8. Epub 2010 Dec 2.

PMID:
21125311
16.

Metalloproteinase 2 cleaves in vitro recombinant TRAIL: potential implications for the decreased serum levels of TRAIL after acute myocardial infarction.

Secchiero P, Gonelli A, Corallini F, Ceconi C, Ferrari R, Zauli G.

Atherosclerosis. 2010 Jul;211(1):333-6. doi: 10.1016/j.atherosclerosis.2010.02.024. Epub 2010 Feb 24.

PMID:
20233617
17.

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, Croce CM.

Cancer Cell. 2009 Dec 8;16(6):498-509. doi: 10.1016/j.ccr.2009.10.014.

18.

Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.

Gonelli A, Milani D, Rimondi E, Voltan R, Grill V, Celeghini C.

Eur J Histochem. 2009 Sep 23;53(3):177-82.

PMID:
19864212
19.

Activation of PKC-ε counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.

Gonelli A, Milani D, Rimondi E, Voltan R, Grill V, Celeghini C.

Eur J Histochem. 2009 Sep 30;53(3):e21. doi: 10.4081/ejh.2009.e21. eCollection 2009 Sep 30. Review.

20.

Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents.

Gonelli A, Mischiati C, Guerrini R, Voltan R, Salvadori S, Zauli G.

Mini Rev Med Chem. 2009 Apr;9(4):498-509. Review.

PMID:
19356127
21.

Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin.

Corallini F, Gonelli A, D'Aurizio F, di Iasio MG, Vaccarezza M.

Eur J Histochem. 2009 Jan-Mar;53(1):19-24.

PMID:
19351609
22.

Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin.

Corallini F, Gonelli A, D'Aurizio F, di Iasio MG, Vaccarezza M.

Eur J Histochem. 2009 Mar 31;53(1):e3. doi: 10.4081/ejh.2009.e3. eCollection 2009 Mar 31. Review.

23.

The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis.

Corallini F, Bossi F, Gonelli A, Tripodo C, Castellino G, Mollnes TE, Tedesco F, Rizzi L, Trotta F, Zauli G, Secchiero P.

Rheumatology (Oxford). 2009 Mar;48(3):293-8. doi: 10.1093/rheumatology/ken495. Epub 2009 Jan 23.

PMID:
19168833
24.

The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies.

Secchiero P, di Iasio MG, Gonelli A, Zauli G.

Curr Pharm Des. 2008;14(21):2100-10. Review.

PMID:
18691119
25.

Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells.

Secchiero P, Melloni E, Tiribelli M, Gonelli A, Zauli G.

J Leukoc Biol. 2008 Feb;83(2):434-7. Epub 2007 Nov 12.

PMID:
17998303
26.

Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.

Secchiero P, di Iasio MG, Gonelli A, Barbarotto E, Melloni E, Tiribelli M, Chiaruttini C, Zauli G.

J Cell Physiol. 2007 Oct;213(1):229-36.

PMID:
17476690
27.

Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus.

Celeghini C, Bortul R, Fadda R, Gonelli A.

Atherosclerosis. 2007 May;192(1):224-6. Epub 2007 Mar 26. No abstract available.

PMID:
17386927
28.

Antiangiogenic activity of the MDM2 antagonist nutlin-3.

Secchiero P, Corallini F, Gonelli A, Dell'Eva R, Vitale M, Capitani S, Albini A, Zauli G.

Circ Res. 2007 Jan 5;100(1):61-9. Epub 2006 Nov 30.

PMID:
17138942
29.

Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL).

Secchiero P, Barbarotto E, Tiribelli M, Zerbinati C, di Iasio MG, Gonelli A, Cavazzini F, Campioni D, Fanin R, Cuneo A, Zauli G.

Blood. 2006 May 15;107(10):4122-9. Epub 2006 Jan 26.

30.

Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.

Secchiero P, Barbarotto E, Gonelli A, Tiribelli M, Zerbinati C, Celeghini C, Agostinelli C, Pileri SA, Zauli G.

Am J Pathol. 2005 Dec;167(6):1599-607.

31.

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release.

Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, Zauli G.

Blood. 2005 May 1;105(9):3413-9. Epub 2005 Jan 11.

32.

TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies.

Secchiero P, Vaccarezza M, Gonelli A, Zauli G.

Curr Pharm Des. 2004;10(29):3673-81. Review.

PMID:
15579063
33.

Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand.

Secchiero P, Gonelli A, Carnevale E, Corallini F, Rizzardi C, Zacchigna S, Melato M, Zauli G.

Neoplasia. 2004 Jul-Aug;6(4):364-73.

34.

In vitro apoptotic cell death during erythroid differentiation.

Zamai L, Burattini S, Luchetti F, Canonico B, Ferri P, Melloni E, Gonelli A, Guidotti L, Papa S, Falcieri E.

Apoptosis. 2004 Mar;9(2):235-46.

PMID:
15004520
35.

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.

Secchiero P, Milani D, Gonelli A, Melloni E, Campioni D, Gibellini D, Capitani S, Zauli G.

J Leukoc Biol. 2003 Aug;74(2):223-32.

PMID:
12885939
36.

TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.

Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, Zella D, Zauli G.

Circulation. 2003 May 6;107(17):2250-6. Epub 2003 Mar 31.

PMID:
12668516
37.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells.

Zauli G, Pandolfi A, Gonelli A, Di Pietro R, Guarnieri S, Ciabattoni G, Rana R, Vitale M, Secchiero P.

Circ Res. 2003 Apr 18;92(7):732-40. Epub 2003 Mar 20.

PMID:
12649264
38.

TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage.

Secchiero P, Gonelli A, Ciabattoni G, Melloni E, Grill V, Rocca B, Delbello G, Zauli G.

J Leukoc Biol. 2002 Nov;72(5):986-94.

PMID:
12429721
39.

Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cells.

Gonelli A, Mirandola P, Grill V, Secchiero P, Zauli G.

Haematologica. 2002 Nov;87(11):1223-5.

40.

Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway.

Secchiero P, Gonelli A, Mirandola P, Melloni E, Zamai L, Celeghini C, Milani D, Zauli G.

Blood. 2002 Oct 1;100(7):2421-9.

41.

Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4(+) T cells.

Secchiero P, Mirandola P, Zella D, Celeghini C, Gonelli A, Vitale M, Capitani S, Zauli G.

Blood. 2001 Oct 15;98(8):2474-81.

42.
43.

Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.

Colamussi ML, Secchiero P, Gonelli A, Marchisio M, Zauli G, Capitani S.

J Leukoc Biol. 2001 Feb;69(2):263-70.

PMID:
11272277
44.

Human herpesvirus 7 is latent in gastric mucosa.

Gonelli A, Boccia S, Boni M, Pozzoli A, Rizzo C, Querzoli P, Cassai E, Di Luca D.

J Med Virol. 2001 Apr;63(4):277-83.

PMID:
11241458
45.

Stroma-derived factor 1alpha induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand.

Gibellini D, Bassini A, Re MC, Ponti C, Miscia S, Gonelli A, La Placa M, Zauli G.

Br J Haematol. 2000 Nov;111(2):432-40.

PMID:
11122082
46.

Phosphoinositide 3-kinase is associated to the nucleus of HL-60 cells and is involved in their ATRA-induced granulocytic differentiation.

Capitani S, Marchisio M, Neri LM, Brugnoli F, Gonelli A, Bertagnolo V.

Eur J Histochem. 2000;44(1):61-5. Review. No abstract available.

PMID:
10868294
47.

Temporal mapping of transcripts in human herpesvirus-7.

Menegazzi P, Galvan M, Rotola A, Ravaioli T, Gonelli A, Cassai E, Di Luca D.

J Gen Virol. 1999 Oct;80 ( Pt 10):2705-12.

PMID:
10573164
48.

U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture.

Rotola A, Ravaioli T, Gonelli A, Dewhurst S, Cassai E, Di Luca D.

Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13911-6.

Supplemental Content

Loading ...
Support Center